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Abstract
Chlamydia trachomatis infects the urogenital tract (UGT) and eyes. Anatomical tropism is
correlated with variation in the major outer membrane protein encoded by ompA. Strains
possessing the ocular ompA variants A, B, Ba and C are typically found within the phyloge-
netically coherent “classical ocular lineage”. However, variants B, Ba and C have also been
found within three distinct strains in Australia, all associated with ocular disease in children
and outside the classical ocular lineage. CtGEM genotyping is a method for detecting and
discriminating ocular strains and also the major phylogenetic lineages. The rationale was
facilitation of surveillance to inform responses to C. trachomatis detection in UGT speci-
mens from young children. CtGEM typing is based on high resolution melting analysis
(HRMA) of two PCR amplified fragments with high combinatorial resolving power, as
defined by computerised comparison of 65 whole genomes. One fragment is from the hypo-
thetical gene defined by Jali-1891 in the C. trachomatis B_Jali20 genome, while the other is
from ompA. Twenty combinatorial CtGEM types have been shown to exist, and these
encompass unique genotypes for all known ocular strains, and also delineate the TI and
T2 major phylogenetic lineages, identify LGV strains and provide additional resolution
beyond this. CtGEM typing and Sanger sequencing were compared with 42 C. trachomatis
positive clinical specimens, and there were no disjunctions. CtGEM typing is a highly effi-
cient method designed and tested using large scale comparative genomics. It divides C.
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trachomatis into clinically and biologically meaningful groups, and may have broad applica-
tion in surveillance.
Introduction
Whole genome-based studies have shown that Chlamydia trachomatis encompasses four
major evolutionary lineages [1–4]. The earliest divergence corresponds to strains associated
the invasive lymphogranuloma venereum (LGV) sexually transmitted infections (STI). The
remainder of the species is divided into the T1 and T2 lineages. A coherent lineage within T2
is composed of trachoma-associated strains from Africa and East Asia, and is termed here the
“classical ocular lineage”. Remaining T2 strains and all T1 strains are associated with non-inva-
sive STIs.
It has long been common practice to define sub-groups within the species C. trachomatis in
accordance with variation in ompA [5–8] which encodes the major outer membrane protein.
OmpA confers variation in immunoreactivity, is associated with tropism towards the urogeni-
tal tract (UGT) or ocular sites, and pathogenic properties. Specifically, the “LGV” ompA geno-
types L1, L2, and L3 are LGV associated, the UGT genotypes D, E, F, G, H, Ia, J, Ja and K are
associated with the non-invasive C. trachomatis STIs, and the “ocular” genotypes A, B, Ba and
C are associated with trachoma and similar ocular disease exhibiting characteristic “face to
face” transmission amongst children. There is significant ompA homoplasy with respect to
evolutionary lineages defined by genome wide SNPs [1–4, 9]. Of particular relevance to this
study, the ocular ompA genotypes B, Ba and C are not only found in the classical ocular line-
age, but also in other lineages isolates from northern Australia, from children with ocular dis-
ease, and strongly associated with the ocular site [2]. These Australian strains are not within
the classical ocular lineage. Three strains were identified. Two were ompA genotypes Ba and C
(termed AusBa and AusC). On the basis of genome wide orthologous SNPs, these are closely
related to each other within the T1 lineage and also closely related to UGT strains of ompA
genotypes E and F. The third Australian strain is ompA genotype B (termed AusB). AusB is
unrelated to AusBa and AusC and is within the T2 lineage, closely related to UGT strains of
ompA genotypes G, H, K and D. A very recent large-scale study of global C. trachomatis
genome diversity has shown that while the AusBa and AusC clones have as yet been found
only in Australia, isolates essentially identical to AusB have been found in Finland and The
Netherlands [3].
The objective of this study was to develop an efficient C. trachomatis genotyping method
that i) discriminated ocular lineages from UGT lineages, ii) discriminated the classical ocular
lineage and the three Australian ocular lineages from each other, and iii) discriminated the
major evolutionary lineages of the entire species. The proximate rationale was the enhance-
ment of the evidence base for interpreting instances of C. trachomatis detection in young chil-
dren in remote northern Australia. The issue of child sexual abuse in remote northern
Australia has a high public profile and is socio-politically contentious [10]. Reports of abuse
led to high profile Australian government interventions [11]. However, the extent and nature
of these behaviours are poorly understood, and the potential for Aboriginal individuals, fami-
lies and communities to be unjustly stereotyped is obvious [10]. While the detection of an STI
agent in a UGT specimen from a young child is normally regarded as highly suggestive of
abuse [12–14], it is difficult to rule out other mechanisms. In particular, the notion of autoino-
culation or contamination of the UGT site from an ocular infection is plausible, particularly in
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areas where trachoma remains endemic. Our conceptual framework is that on-going genotype
surveillance of C. trachomatis in UGT specimens in the adult/post pubescent population will
provide a comparator for genotypes found in young children, when instances of possible abuse
are being investigated [15, 16]. Of particular significance is that a 1980s-90s survey in the
remote Northern Territory of Australia, revealed that ocular serovar B isolates were frequently
found in adult cervical swabs, strongly suggesting transmission of this serovar through sexual
networks [2, 17, 18]. In a much more recent survey that encompassed the same part of Austra-
lia [16], ocular strains were not detected in adult UGT specimens, indicating that serovar B
strains were no longer being transmitted in sexual networks at a detectable frequency. We rea-
son that if ocular strains are absent from adult sexual networks, then an ocular genotype C. tra-
chomatis from a paediatric UGT specimen does not provide evidence for contact with adult
sexual networks and may be suggestive of autoinoculation, or of similar processes that drive
trachoma transmission. Conversely, if nominally ocular strains are prevalent in sexual net-
works, then the genotype of the strain in a paediatric specimen is less informative of origin
[15].
The technology platform chosen was high resolution melting analysis (HRMA) [19–21],
because of its simplicity and low cost, and the generic instrumentation. The genotyping
method we developed meets the performance requirements specifications and is suitable for




The conceptual and technical basis of the method resembles “Minim typing’ which makes use
of HRMA of fragments within multilocus sequence typing (MLST) loci that are nucleated by
SNPs selected for high combinatorial resolving power [22–25]. However, in this study we
derived SNPs from whole genome information rather than MLST data. A detailed account
of the development of the method is provided (S1 File) In brief, an alignment of alleles at
genome-wide orthologous SNPs derived from 65 representative C. trachomatis genomes was
mined for SNP combinations with high Simpsons Index of Diversity using the software Mini-
mum SNPs [26, 27]. It was found that maximal resolving power from two SNPs was obtained
when one of the SNPs was the tri-allelic SNP defined by position 222834 in the C. trachomatis
B_Jali20 genome [28] (NC_012686.1), and the other was any of a number of SNPs within
ompA. This led us to conjecture that a method encompassing both these loci would identify
ocular strains and discriminate major phylogenetic groups. The SNP at position 222834 is
within a hypothetical gene (Jali-1891) that is annotated as encoding a hypothetical protein that
is likely membrane located [28]. There is another SNP at position 222832, and together these
define four haplotypes of GA, GT, GC and AT (shown in order of 222832-G/A, 222834-A/T/
C). Robust HRMA-based discrimination of these haplotypes was achieved, with the adoption
of a nested PCR format in which the second round PCR was an asymmetric PCR which incor-
porated an unlabelled probe (Fig 1). We term the amplified region “region 1’ which is abbrevi-
ated to “rg1”.
To develop an HRMA based on ompA, we determined that a fragment used in a previously
described HRMA assay to discriminate ompA genotypes B and Ba [16] may have broader
applicability for discriminating ompA variants. This fragment encompasses the ompA region
that encodes the OmpA variable domain 3. A semi-nested PCR and HRMA assay was devel-
oped using control strains that divided the ompA genotypes into the following groups: Ba+D,
B+F, C+H+Ia+J+Ja+K, L1+L2, A, E and G (Fig 2). At this time L3 variants remain untested,
CtGEM typing for discriminating Chlamydia trachomatis lineages
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Fig 1. HRMA analysis of the region 1 fragment (rg1). (A) Sequence alignment of the four known haplotypes of rg1
showing the primer sequences (grey shading) and probe sequence (yellow shading). (B) HRMA curves showing the
resolution of the four haplotypes.
https://doi.org/10.1371/journal.pone.0195454.g001
Fig 2. HRMA analysis of the ompA fragment (ofr). (A) Sequence alignment of the known haplotypes of ofr showing
the primer sequences (grey shading). (B) HRMA curves showing the resolution of the genotypes. A detailed guide for
the HRMA is given in S2 File in the supplemental material.
https://doi.org/10.1371/journal.pone.0195454.g002
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but are predicted to produce a unique HRM curveWe termed the amplified fragment “ompA
fragment” which is abbreviated to “ofr”. An alignment of variation in the ofr is shown in Fig 2.
A detailed procedure for assigning curves to HRMA alleles is shown in S2 File.
We elected to number the rg1-ofr combinatorial genotypes from 1–32, in accordance with
all possible combinations of the four HRMA alleles of rg1 and eight HRMA alleles of the ofr,
even though all 32 genotypes may not exist in nature. We named the procedure “Chlamydia
trachomatis genotyping by melting” (CtGEM), and refer to the genotypes from this method as
CtGEM types 1–32. Detailed information regarding the CtGEM types, and their relationship
to the phylogeny and ompA allelic status are provided in Table 1.
In silico assessment of assay performance
The availability of many whole genome data sets enabled us to assess in silico the performance
of CtGEM typing across known diversity of the species. First, we determined how the genotyp-
ing assay would be predicted to resolve the 65 genomes used to design the CtGEM typing.
It can be seen in Fig 3 that that the predicted performance of the assay meets requirements.
The 20 CtGEM types defined by these genomes encompass four CtGEM types containing
only “classical ocular” genomes, and three CtGEM types containing only Australian ocular
B, Australian ocular Ba, and Australian ocular C genomes. In intuitive terms, rg1 resolves C.
trachomatis into the T2 lineage (haplotype GA), the T1 lineage (haplotype GT, AT and rare
occurrences of GA), and the classical ocular lineage plus the L1 and L2 lineages (haplotype
GC). It is fortuitous that the combinatorial resolving power of the two fragments is what is
required for the method to meet the performance requirements. In particular, the Australian
ocular genomes are resolved from their close UGT-associated relatives on the basis of ompA
HRMA types. Also fortuitous are the distinctive ompA HRMA curves we obtained from ompA
genotypes E, A and L1/L2. Upon careful analysis of the sequence data we noted that the LGV
associated L1-440 has an aberrant ofr sequence that is predicted to yield an HRMA curve
indistinguishable from the ofr Ba+D curve. Because L1-440 possesses the rg1 GC haplotype,
this strain is predicted to be CtGEM type 25, as for ompA genotype Ba strains in the classical
ocular lineage, and accordingly should be regarded a false positive for an ocular strain.
For the second stage of the in silico experiments, we extended the analyses to a much larger
recently published set of whole genome information of C. trachomatis isolates, comprising the
65 genomes we had already considered and 494 additional genomes (Table 2). Two questions
were addressed. First we looked for additional in silico inferred CtGEM types that consist of
Table 1. CtGEM types defined by 559 genomes.
HRMA alleles of ofr
Rg1
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previously unseen combinations of known sequence variants i.e. CtGEM types encompassed
by the CtGEM nomenclature but not known to exist prior to this analysis. Second, we searched
for previously unidentified SNPs that have potential to confound the HRMA’s we have devel-
oped. The rg1 and ofr sequence was determined from the available short read sequencing data
using ARIBA [29]. The isolates overwhelmingly conformed to relationship between CtGEM
type, phylogenetic position, and tropism previously defined by the 65 genomes. However
novel recombinants were identified. Eleven of the strains with non-ocular ompA genotypes
would be predicted to generate a false positive in a screen for classical or Australian ocular iso-
lates. OmpA genotype F strains 11–96 and Fin106 possess the rg1 GA haplotype (CtGEM type
2), as does AusB. OmpA genotype D isolates NL4, NL5, NL6, NL8, NL19, Fin163 and S2761
have the rg1 haplotype GT (CtGEM type 9), as does AusBa. OmpA genotype J strains J_NL55
and J_Sou106 possess the rg1GT haplotype (CtGEM type 11), as does AusC. No novel SNPs
Fig 3. Relationship between rg1 and HRMA alleles alone and in combination, and C. trachomatis phylogeny. The
phylogenetic tree is based on genome-wide orthologous SNPs and adapted from Andersson et al (2). HRMA alleles
and CtGEM types are indicated with colours.
https://doi.org/10.1371/journal.pone.0195454.g003
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were identified in region 1. Novel SNPs in the HRMA fragments were extremely rare and in
only one instance was predicted on the basis of G+C content to impact the HRMA curve. This
was strain S4641, which possesses a novel ompA sequence for which it is unclear whether to
classify as genotype E or genotype G. The ofr sequence is predicted to yield a curve indistin-
guishable from ompA genotype G. The rg1 haplotype is AT, so the predicted CtGEM result is
type 24. Strain S4641 is the only known or putative representative of CtGEM type 24.
Table 2. Descriptions of the CtGEM types, and the numbers and frequencies of the types in sets of genomes/clinical specimens.




1 rg1GA-ofrBaD D in T2 T2 39 (7.0) 8 (13.8)
2 rg1GA-ofrBF Ocular AusB T2 11a (2.0) 0
3 rg1GA- ofrCHIaJJaK Non-ocular T2 not D or G T2 88 (15.7) 12 (20.7)
4 rg1GA-ofrLx Not found - 0 0
5 rg1GA-ofrA Not found - 0 0
6 rg1GA-ofrL3 Not found - 0 0
7 rg1GA-ofrE GA E T1 32 (5.7) 2 (3.5)
8 rg1GA-ofrG Typical G T2 59 (10.6) 4 (6.9)
9 rg1GT-ofrBaD Ocular AusBa T1 9b (1.6) 1c (1.7)
10 rg1GT-ofrBF GT F T1 29 (5.2) 3 (5.2)
11 rg1GT- ofrCHIaJJaK Ocular AusC T1 7d (1.3) 1e (1.7)
12 rg1GT-ofrLx Not found - 0 0
13 rg1GT-ofrA Not found - 0 0
14 rg1GT-ofrL3 Not found - 0 0
15 rg1GT-ofrE Typical E T1 105 (18.8) 16 (27.6)
16 rg1GT-ofrG Not Found - 0 0
17 rg1AT-ofrBaD D in T1 T1 13 (2.3) 1 (1.7)
18 rg1AT-ofrBF AT F T1 37 (6.6) 8 (13.8)
19 rg1AT- ofrCHIaJJaK T1 J T1 1 (0.2) 1 (1.7)
20 rg1AT-ofrLx Not found - 0 0
21 rg1AT-ofrA Not found - 0 0
22 rg1AT-ofrL3 Not found - 0 0
23 rg1AT-ofrE AT E T1 9 (1.6) 1 (1.7)
24 rg1AT-ofrG AT G T2 1 (0.2) 0
25 rg1GC-ofrBaD Ocular classic Ba Ocular 2f (0.4) 0
26 rg1GC-ofrBF Ocular classic B Ocular 5 (0.9) 0
27 rg1GC- ofrCHIaJJaK Ocular classic C Ocular 3 (0.5) 0
28 rg1GC-ofrLx LGV L1,L2,L2a LGV 56 (10.0) 0
29 rg1GC-ofrA Ocular classic A Ocular 52 (9.3) 0
30 rg1GC-ofrL3 LGV L3 LGV 1 (0.2) 0
31 rg1GC-ofrE Not found - 0 0
32 rg1GC-ofrG Not found - 0 0
Total 559 58
a The 11 CtGEM type 2 genomes in the global set encompass nine ocular AusB isolates and two false positives for this strain.
b The nine CtGEM type 9 genomes in the global set encompass two ocular AusBa isolates and seven false positives for this strain.
c The single CtGEM type 9 strain in the clinical specimens is a false positive for the AusBa strain.
d The seven CtGEM type 11 genomes in the global set encompass five ocular AusC isolates and two false positives for this strain.
e The single CtGEM type 11 strain in the clinical specimens is a false positive for the AusC strain.
f The two CtGEM type 25 genomes in the global set encompasses one classical ocular Ba isolate and one false positive for this strain.
https://doi.org/10.1371/journal.pone.0195454.t002
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The number of predicted CtGEM false positives for ocular strains is 12; one from the 65
genome set and a further 11 from the additional 494 genomes, as indicated above. Of the 559
genomes in the total set, 89 have ocular ompA genotypes, so there are 470 true negatives for
ocular strains. Specificity = true negatives/(true negatives + false positives), so this equates to a
specificity of 0.975 if CtGEM typing were used to screen the 559 genomes for ocular strains.
Six of the false positives are “NL” strains from the Netherlands. The equivalent specificity for
“NL’ designated isolates alone is 0.902, showing that there is potential for regional variation.
The inferred sensitivity for ocular strains is 1.0, primarily because of absolute linkage
between the classical ocular and L lineages, and the rg1 GC haplotype.
It was concluded that CtGEM typing enables screening for ocular strains with high sensitiv-
ity and specificity, and also provides a low resolution but robust indication of evolutionary
position as defined by genome wide orthologous SNP-based phylogenetic inference.
Testing using clinical specimens
The robustness of CtGEM typing was tested using 113 C. trachomatis positive UGT clinical
specimens, obtained from public pathology service providers in the Australian state of Queens-
land. To generate a gold standard comparator, the regions subjected to HRMA were first ana-
lysed by Sanger sequencing of PCR fragments, in a different laboratory to where the CtGEM
typing was performed. For both targets, specimens were tested either once or twice. For rg1, a
subset of specimens where genotyping failed was re-tested, but this did not increase the success
rate. For ofr, a subset of specimens that initially failed to be genotyped was re-tested using a
reaction that incorporated a small reduction in the primer annealing temperature (the condi-
tions for the repeat reactions are the conditions incorporated in the final definitive procedure).
This resulted in six initially “fail” specimens being successfully genotyped.
The results are summarised in Table 3, and complete results are in S3–S5 Files. There were
no inconsistencies between HRMA and Sanger sequencing. Also, the CtGEM types obtained
and their relative abundances were similar to that shown by the in silico analysis of genome
sequences. The predominant mode of failure was complete amplification failure, and there was
considerable consistency between failure of HRMA and failure of sequence determination
(Table 3), suggesting that failure was due to low target concentration or PCR inhibition. For
Table 3. Numbers and percentages of successful PCR amplifications from 113 C. trachomatis positive clinical
specimens.
CtGEM typing Sequencing Number (%)
rg1 ofr rg1 ofr
+ + + + 42 (37.2)
+ + - - 10 (8.8)
- + + + 5 (4.4)
- - + + 1 (0.9)
- + - - 4 (3.5)
+ - - - 10 (8.8)
- - - - 41 (36.3)
Totals
CtGEM typing 52 (46.0)
Sequencing 48 (42.5)
CtGEM rg1 62 (54.9)
CtGEM ofr 61 (54.0)
https://doi.org/10.1371/journal.pone.0195454.t003
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three specimens (58, 77 and 83), complete failure of rg1 amplification was not observed, but
probe melting was not sufficiently clear to reliably discriminate between the GA and GT hap-
lotypes. It was of interest that only two of the specimens yielded CtGEM types consistent with
ocular strains. Specimen 81 is CtGEM type 9, which corresponds to the AusBa strain. The ini-
tial attempt to obtain sequence from specimen 81 was unsuccessful. However, we made addi-
tional efforts to sequence the HRMA loci and it was determined that it was ompA genotype D
and so a false positive for an ocular strain. Specimen 96 yielded CtGEM type 11 which corre-
sponds to the AusC strain. However, the ompA sequence indicated that it was ompA genotype
Ja, and so also a false positive for an ocular strain. Complete CtGEM types were obtained by
CtGEM typing and/or sequencing from 58 clinical specimens and none have ocular ompA
genotypes.
Discussion
The accumulation of complete genome information from large numbers of isolates within a
bacterial species makes it possible to design genotyping methods with precisely designed per-
formance. However, this raises the question as to whether the recent very large cost reductions
in whole genome sequence analysis have largely rendered bacterial genotyping methods obso-
lete. Our position is that there is a role for genotyping methods for high throughput surveil-
lance or research, provided they are considerably faster and cheaper than genome sequencing,
and yield useful information. CtGEM typing encompasses two PCR reactions for each of two
loci, using a generic SYBR green master mix. The procedure can be completed in three hours,
and has a consumables cost of<AUD$3.00 per assay, not including any costs associated with
nucleic acid purification. This is much faster and cheaper than whole-genome based methods.
Furthermore, C. trachomatis is difficult and time consuming to culture, which makes methods
based on direct analysis of clinical specimens especially useful. Direct genome sequencing of
C. trachomatis from clinical specimens remains a significant technical task [3], so expanding
the potential role for non-sequencing based methods. Most other C. trachomatis genotyping
typing methods either target ompA alone and are frequently complex [30–32], or are MLST or
variable number tandem repeat based methods [33–38] that in terms of cost and time taken
may now have difficulty in competing with full genome-based methods. Very low cost and
rapid methods for C. trachomatis genotyping are in general designed only to identify specific
subgroups [39, 40]. For example the method developed by Schlaeffer and Henrich [40] resem-
bles CtGEM typing in that it targets ompA and one other gene, but it provides typing informa-
tion only within the LGV lineage. CtGEM provides a unique synthesis of low cost, simplicity,
and species-wide informative power. CtGEM typing is not suitable for contact tracing, or the
inference of high resolution transmission networks, but would be highly effective for low cost
monitoring of major lineages. We suggest that the availability of CtGEM typing and whole
genome sequence analysis could underpin most conceivable C. trachomatis surveillance tasks.
The key driver for the development of CtGEM typing was the facilitation of the high
throughput screening of C. trachomatis positive UGT specimens for the presence of known
ocular strains [15, 16]. The two fragments selected for inclusion in the method make it particu-
larly effective for this purpose. We took a conservative approach of defining only eight HRMA
alleles of ompA meaning that not all omA genotypes are discriminated by the ofr HRMA.
However, in a fortuitous manner, the rg1 HRMA not only discriminates the ocular from the
UGT strains in these groups, but also discriminates the Australian ocular strains from the clas-
sical ocular strains. The effectiveness of the method is enhanced by the absolute correlation
between the rg1 GC allele and the classical ocular and LGV lineages, and the rarity of ompA
genotype D strains that have the rg1 GT allele. Both ompA genotype D and the rg1 GT allele
CtGEM typing for discriminating Chlamydia trachomatis lineages
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are common in the C. trachomatis T1 lineage, but they very rarely coincide to generate CtGEM
type 9 false positives for the ocular AusBa strain.
Not only does CtGEM typing identify specific ocular strains, it can also assign strains to the
T1, T2, classical ocular, and LGV lineages. The rg1 GA allele is a virtually 100% sensitive
marker for the T2 lineage. The specificity is less because there is a lineage of ompA genotype E
strains in the T1 lineage that also has the rg1 GA allele. However, there are no known genotype
E strains in the T2 lineage, so the combination of the GA allele in rg1 and “not E” at ompA is
very sensitive and specific for the T2 lineage. Conversely, a GT or AT allele at rg1, or a combi-
nation of the ompA genotype E allele and the rg1 GA allele is very sensitive and specific for the
T1 lineage. The rg1 GC allele is sensitive and specific for the classical ocular and LGV lineages.
Within the strains that possess the rg1 GC allele, the ompA HRMA method generates unique
curves for A, Ba, B, C, and L1/2 (LGV) ompA genotypes.
It is inevitable that such a streamlined method as CtGEM typing has limitations. First, given
that the method is based on known genetic variation, it is inherently vulnerable to being com-
promised by undiscovered variation. However, the recently publication of hundreds of C. tra-
chomatis genome sequences from all over the world provided an extremely valuable resource
[3]. We demonstrated the relationship between CtGEM typing and population structure
defined by the smaller set of genomes used to design the method remains valid with the larger
set of genomes. Also, while there is concordance between CtGEM type relative abundances in
the global set of genomes, and clinical specimens from Queensland, the global set of genomes
contained no strains of ompA genotype Ja, whereas these are quite common in the Queensland
set. Further, one Queensland ompA genotype Ja strain possessed a rg1 GT haplotype (as
opposed to the expected T2 associated GA haplotype that was found in the other Queensland
ompA genotype Ja strains). The combination of rg1 haplotype GT and the ofr CHIaJJaK allele
is CtGEM type 11, the same as the AusC strain. Therefore this strain constitutes a single false
positive for the ocular AusC isolates, that is absent from the global set of genomes [3]. As dis-
cussed below, ofr sequencing would show that this strain is not AusC.
The global set of genomes defined only a small number of additional SNPs in the regions
subject to HRMA, and these were in very rare strains, The predicted effects on HRMA are to
produce novel curves rather than to result in HRMA allele mis-calling. It may be that in the
future the CtGEM allele designations and genotype numbering system will be expanded. How-
ever, the current protocol is predicted to be valid for the vast majority of extant C. trachomatis
strains.
The CtGEM data analysis protocol specifies that ompA genotypes C, H, Ia, J, Ja, and K are
not discriminated from each other. We regard this as acceptable because these ompA variants
are closely related [41–43] and the UGT associated ompA genotypes in this group (i.e. not C)
are associated with the T2 lineage and appear to have similar distributions and ecology [1, 3].
Sequencing ofr with the CHIJJaK s HRMA curve would resolve the fragment into four classes
composed of ompA genotypes C, K, Ja, and H+Ia+J (Fig 2). OmpA genotypes H, Ia, and J have
identical ofr sequences so cannot be discriminated by sequencing. Importantly for screening for
ocular strains based on current knowledge a T at position 67 in the ofr is 100% sensitive and
specific for genotype C. We have observed that the ofr’s from genotypes C, K, and Ja melt at a
lower temperature than those from genotypes H, and J (and inferred from Ia which has an iden-
tical ofr sequence). However, we have taken a conservative approach and not incorporated this
into our protocol for data analysis, primarily because this still fails to provide 100% specificity
for ompA genotype C. We therefore suggest sequence analysis of the ofr if more discrimination
is needed, in particular when confirming the identification of an ompA genotype C strain strain.
A critical aid to the interpretation of the ofr HRMA is a conspicuous early melting domain
in the ofr’s from genotypes C, H, Ia, J, Ja and K (experimentally demonstrated for all except
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ompA genotype Ia, which has an identical ofr sequence to genotypes H and J). The ofr from
ompA genotype A has an identical sequence to ompA genotypes H, Ia, and J except for a T!C
substitution at ofr position 140, and although there is evidence for an early melting domain
from ompA genotype A, it is much less conspicuous a than in HRMA curves from C, H, Ia, J,
Ja, and K. This suggests that the existence of the conspicuous early melting domain is largely
dependent on a T at position 140. The association between the allelic state of the position 140
T-C SNP and the nature of the early melting domain is only seen with the closely related ompA
genotypes A, C, H, Ia, J, Ja, and K derived ofr sequences. Apart from the ofr derived from
ompA genotype L3, all other known ofr variants possess a T at position 140, and yet do not
have the ofr early melting domain. This is explicable as there are many differences between ofr
sequences from ompA H, Ia, J, Ja, K, and the other variants of ompA, which could easily change
the melting domain structure. Further, there was complete concordance between our observa-
tions of early melt domain magnitude and presence/absence, and in silico prediction using the
software uMELT [44] (data not shown).
A minor limitation of the study is that we have not fully defined the ability of CtGEM typing
to identify C. trachomatis LGV strains. We experimentally established that the ompA L2 geno-
type ofr generates a unique HRMA curve, and the ofr’s from ompA genotypes L1, L2 and L2b
are identical, so these ompA genotypes should all be identified. An exception is the very rare
aberrant ompA sequence from strain L1-440, which is predicted to be indistinguishable from
classical ocular genotype Ba by CtGEM typing. We have not tested any L3 strains, which have an
ofr very similar to ompA genotype A, differing only in having a C instead of a T at ofr position
127. We predict, using both uMELT [44], and comparison with observed curves, that ompA
genotype L3 will yield an ofr melting curve similar but not identical to genotypes A, E and G.
However, LGV strains all possess the rg1 GC haplotype, whereas genotypes E and G strains with
rg1 haplotype GC have not been found. Genotype A and L3 strains share the rg1 GC haplotype
so are potentially difficult to discriminate by CtGEM typing. However genotype A strains are
ocular, while LGV strains are associated with invasive STIs, and genotype L3 and A strains can
be discriminated by ofr sequencing. Therefore, we feel this limitation is manageable.
There was a failure rate of 54% when the HRMA method was tested against clinical speci-
mens, with failure being almost entirely due to lack of PCR amplification. The proportion of
failures, and the identities of the specimens that failed were very similar for CtGEM method,
and for amplification followed by sequencing of the same loci. This suggests that PCR am-
plification failure is a consequence of low C. trachomatis DNA concentration. Amplification
sensitivity is a common issue with C. trachomatis typing methods based on direct PCR amplifi-
cation from clinical specimens, probably because of great variability in the mass of C. tracho-
matis DNA in clinical specimens, and the high sensitivity of commercial diagnostic systems
which often target the multicopy resident plasmid and make use of larger volumes of purified
nucleic acid than the 1μl used by us. It was noted that failure in a second stage PCR was always
preceded by undetectable amplification in first round PCR, whereas with successful amplifica-
tion, amplimer was always detectable after the first round PCR. Our reasoning is amplification
failure is due to complete failure of amplification to commence, and the primary function of
adopting a nested or semi-nested PCR formats is not to maximise amplification sensitivity, but
to achieve consistency in final PCR yield and so enhance the HRMA robustness. There is
scope for improvement of PCR sensitivity. First, it was not uncommon to see amplification
failure of one or other of the loci, suggesting that the PCR reactions for one locus are not inher-
ently more sensitive than for the other. Rather it indicates there is a stochastic element to fail-
ure that could be addressed by repetition of the amplification reactions. Second, concentrating
the nucleic acid purified from the specimens, and/or increasing the nucleic acid solution vol-
ume in the reaction, may increase sensitivity.
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In conclusion, we have developed and demonstrated HRMA-based CtGEM typing, a low
cost and efficient means of subdividing C. trachomatis into types concordant with phylogeny
and anatomical tropism. CtGEM typing is likely applicable to C. trachomatis surveillance in
research or public health contexts. If used for screening for ocular strains, it has 100% sensitiv-
ity and sufficient specificity to exclude the great majority of ocular strains. Further identifica-
tion of ocular strains can be confirmed by sequencing of ofr.
Materials and methods
C. trachomatis isolates and specimens, and DNA extraction
C. trachomatis isolates (Aus3, Aus9, Aus11, Aus15, Aus19, Aus20, and Aus25) were obtained
from a study of mother and child pairs conducted in the Northern Territory, Australia between
1985 and 1993 [2, 17]. DNA was extracted from three 25cm3 culture flasks at 80–100% infectiv-
ity stored at -80˚C using a QIAamp DNA Mini Kit (Qiagen, Chadstone, Australia).
Genome-sequenced C. trachomatis reference strains A2497 [1] and UCH1 [45] were
obtained from the Chlamydia Biobank, University of Southampton, UK. The strains were cul-
tured in HeLa cell monolayers which were propagated in DMEM supplemented with 10% foe-
tal calf serum. The inocula were centrifuged onto a confluent monolayer at 750xg for 30
minutes at room temperature. Infected cultures were grown in DMEM with 10% foetal calf
serum plus 1μg/mL cyclohexamide and 20μg/mL gentamicin to 80–100% infectivity. Elemen-
tary bodies were harvested from three 25cm3 culture flasks by scraping the cells from the sur-
face of the flask and centrifuging at 3000xg. The cell pellet was resuspended in cold PBS
containing glass beads and vortexed at high speed for 1 minute to lyse the cells. Cell debris was
removed by centrifugation at 250xg for 5 minutes and DNA was extracted from the elementary
bodies in the supernatant using a GenElute Bacterial Genomic DNA Kit (Sigma-Aldrich, Syd-
ney, New South Wales).
PS297 is a C. trachomatis-positive diagnostic urogenital swab specimen, collected as part of
a prospective study of C. trachomatis genotypes in the Northern Territory, Australia [16].
Royal Darwin Hospital diagnostic laboratory staff extracted DNA from the specimen using the
Siemens Versant system (Siemens Healthcare Australia, Bayswater, Victoria).
DNA from reference strain ATCC VR-902B was purchased as Amplirun1 C. trachomatis
DNA control (Vircell, Madrid, Spain).
C. trachomatis-positive clinical samples from Queensland, Australia were collected as part
of a study to understand current serovar and genetic differences in ocular and urine samples.
Specimens were urine remnant DNA extracts from the Roche 4800 CT/NG test (Roche Diag-
nostics, Australia).
Identification of informative SNP combinations
We used a previously described genome-wide orthologous SNPs matrix inferred from whole
genome sequencing data from 65 diverse C. trachomatis isolates [2]. The orthologous SNP
matrix was used as input into the computer program “Minimum SNPs” [26, 27]. This program
can derive sets of SNPs from DNA sequence alignments based on maximised Simpson’s index
of Diversity (D). In this context, D is the probability that two known sequence variants chosen
at random from the alignment (without replacement), will be discriminated by the SNP set
under test. Combinations of SNPs were assessed for informative power in silico, to determine a
maximally efficient means of meeting the assay specifications. This process included manual
investigations of the feasibility of PCR primer design, and the potential effects of other nearby
SNPs which have the potential to add resolving power, or conversely, confound an HRMA
assay if the SNPs are linked and have opposing effects on amplimer G+C content.
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Genotyping procedure
The optimised method encompasses the HRMA analysis of two DNA fragments, one within
ompA, and the other within a universally present putative membrane protein-encoding gene
that is annotated as Jali_1891 in the genome of isolate B_Jali20, which we designated “region
1”. The format was a nested (region 1) or semi-nested (ompA) PCR in which the products of
the first round PCR were subjected to a second round of PCR, followed by HRMA. For the
region 1 fragment, an unlabelled probe and second round asymmetric PCR were used to facili-
tate discrimination of known variants.
The primer and probe sequences, and PCR and HRMA temperature conditions are shown
in Table 4. All PCR reactions were performed in a QIAGEN Rotorgene device using Plati-
num1 SYBR1 Green qPCR SuperMix-UDG chemistry (Invitrogen) with the addition of 5%
Q-solution (5M betaine) in a total volume of 10μl. For the ompA fragment (ofr), the first
round PCR contained 0.4μM of each primer and 1μl of DNA extraction. The second round
PCR and HRMA reaction contained 1μl of the first round PCR product and 0.4μM of each
primer. For the region 1 fragment (Rg1), the first round PCR contained 0.5μM of each primer
and 1μl of DNA extraction. The second round PCR and HRMA reaction contained 1μl of the
first round PCR product, 0.04μM of the forward primer, 0.4μM of the reverse primer, and
1μM of the probe. A detailed account of the assay design and method development is given in
S1 File. Isolates of known genotype that were used in the development of the assay are shown
in Table 5. The work-flow for analysing the HRMA data is provided in S2 File.
Sequencing of rg1 and ofr from clinical specimens
Each region was initially amplified by PCR using the primers described in Table 4. PCR prod-
ucts were purified and Sanger sequenced by service providers, the Australian Genome
Research Facility (Brisbane, Australia).
Table 4. PCR primer and probe sequences, and PCR and HRMA conditions.
Region
name
PCR reaction Oligo Oligo sequence (5’-3’) Product
size (bp)
PCR and HRMA conditions HRMA
normalisation
regions (ToC)
rg1 First round FR CATCCACTTTACCAGCGATTC 193 50˚C 2min; 95˚C 2min;50 cycles of 95˚C
10secs, 61–56˚C (1˚C per cycle) 10secs,




FRprobe GGAAAGGTCAGCACTCTTGAA 74 50˚C 2min; 95˚C 2min;50 cycles of 95˚C
10secs, 61–56˚C (1˚C per cycle) 10secs,
72˚C 20secs;95˚C 1min; 40˚C 1min;50–





Sequencing FR CCCATTGCCGAGAGATAAAA 354
CTCCTGCGGAGGTTAGATTG
ofr First round FR TCCTACTGCAATACCGCAAG
GCTTCTTTCCAATATGCTCAATC
459 50˚C 2min; 95˚C 2min;50 cycles of 95˚C
10secs, 59–54˚C (1˚C per cycle) 10secs,





184 50˚C 2min; 95˚C 2min;50 cycles of 95˚C
10secs, 59–54˚C (1˚C per cycle) 10secs,
72˚C 40secs;95˚C 1min; 40˚C 1min;65–
95˚C in 0.1˚C increments for 2secs
73–74˚C83-84˚C
Sequencing FR TCCTACTGCAATACCGCAAG 1015
TGAACCAAGCCTTATGATCG
https://doi.org/10.1371/journal.pone.0195454.t004
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In-silico assessment of assay performance
The original 65 genome dataset [2] and additional genome sequence data from a global study
of C. trachomatis phylogeny [3] were analysed in silico to determine their CtGEM type. A refer-
ence set of known genotypes from the 65 genomes [2] used in the design of the assay, was gen-
erated for each of the two HRM fragments. For ofr, the reference genotypes were 184bp which
corresponded to the ompA fragment HRM amplicon. For rg1, the reference genotypes were
400bp which encompassed the 74bp of the region 1 HRM amplicon. Short read genome
sequence data for individual isolates was aligned against the reference genotypes for ofr and
rg1 using ARIBA [29]. Of the 563 genomes in the global study [2], 63 were already included in
our original dataset of 65 genomes, and 2 isolates we were unable to obtain short read data for
(D_UK750364 and E_UK220880), providing an additional 498 genomes for analysis. Of the
563 genomes thus analysed in total, 4 did not produce a result for one of both or the CtGEM
fragments (B_Aus6, F_Swab5, L2_P, and A_MH20130), yielding complete CtGEM predictions
for 559 isolates.
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Supporting information
S1 File. Method development. Additional information regarding development of the CtGEM
method.
(DOCX)
Table 5. Control isolates used during development of CtGEM typing.
ofr controls Genome accession ofr genotype ofr curve
A2497 FM872306 A A
Aus3 ERS153020 B BF
Aus25 ERS351392 Ba BaD
Aus9 ERS153045 C CHIJK
Aus11 ERS153024 D BaD
Aus15a - E E
Aus20 ERS153031 F BF
Aus19 ERS153037 G G
UCH1 ERS001407 L2b L
rg1 controls Genome accession rg1 genotype rg1 curve
ATCC VR-902B - GC GC
Aus3 ERS153020 GA GA
Aus9 ERS153045 GT GT
PS297b - AT AT
a Aus15 was serotyped as a serovar E [2, 17] and shown to have an identical ofr curve to clinical samples analysed in
this study which had an ofr E sequence.
b PS297 is a clinical sample [16] for which rg1 was sequenced and confirmed as an AT genotype.
https://doi.org/10.1371/journal.pone.0195454.t005
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S2 File. HRMA curve interpretation. A detailed protocol for HRMA curve interpretation.
(DOCX)
S3 File. Rg1 sequences. Rg1 sequences derived from the Queensland specimens.
(TXT)
S4 File. Partial ompA sequences. Partial ompA sequences derived from the Queensland speci-
mens.
(TXT)
S5 File. Complete HRMA results. Genotypes inferred from HRMA, and HRMA raw data.
(XLSX)
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